Revenue
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $322.2M | $616.6M | $624.3M | $440.5M | $318.7M | $94.1M |
| Research & development | $13.6M | $11.6M | $10.9M | $5.4M | $3.3M | $1.2M |
| Operating expenses | $500.2M | $587.9M | $609.2M | $418.7M | $303.4M | $108.8M |
| Operating income | −$178.0M | $28.7M | $15.1M | $21.8M | $15.4M | −$14.8M |
| EBITDAderived | −$162.4M | $44.6M | $31.5M | $32.4M | $17.7M | −$9.3M |
| Net income | −$182.4M | $20.0M | $6.9M | $34.6M | $23.7M | −$14.8M |
| Basic EPSper diluted share | -$1.84 | $0.20 | $0.07 | $0.34 | $0.30 | -$0.25 |
| Diluted EPSper diluted share | -$1.84 | $0.18 | $0.06 | $0.34 | $0.25 | -$0.25 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 15, 2025Form 4 | Tendler Ely DGeneral Counsel and Secretary | SellCommon Stock | 16.9K | $0.91 | $15.3K | 258.8K |
| May 23, 2025Form 4 | Burdiek Michael JDirector | BuyCommon Stock | 10.0K | $1.33 | $13.3K | 641.6K |
| May 15, 2025Form 4 | Burdiek Michael JDirector | BuyCommon Stock | 15.0K | $1.43 | $21.4K | 631.6K |
| May 14, 2025Form 4 | Klasko Stephen K. M.D.Director | BuyCommon Stock | 15.0K | $1.49 | $22.4K | 15.0K |
| May 14, 2025Form 4 | Sugrue StephenChief Compliance Officer | BuyCommon Stock | 10.0K | $1.44 | $14.4K | 357.3K |